JW (Cayman) Therapeutics Co. Ltd (JWCTF)
USD 0.17
(0.0%)
USD 0.17
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 197.79 Million CNY | 56.69% |
| 2022 | 126.22 Million CNY | -0.49% |
| 2021 | 126.84 Million CNY | 12.54% |
| 2020 | 112.71 Million CNY | 66.52% |
| 2019 | 67.68 Million CNY | 335.62% |
| 2018 | 15.53 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 141.1 Million CNY | -10.41% |
| 2024 Q2 | 141.1 Million CNY | 0.0% |
| 2023 FY | 197.79 Million CNY | 56.69% |
| 2023 Q3 | 197.79 Million CNY | 21.04% |
| 2023 Q2 | 163.4 Million CNY | 0.0% |
| 2023 Q1 | 163.4 Million CNY | 29.45% |
| 2023 Q4 | 197.79 Million CNY | 0.0% |
| 2022 Q4 | 126.22 Million CNY | 0.0% |
| 2022 Q2 | 127.68 Million CNY | 0.0% |
| 2022 Q1 | 127.68 Million CNY | 0.66% |
| 2022 FY | 126.22 Million CNY | -0.49% |
| 2022 Q3 | 126.22 Million CNY | -1.14% |
| 2021 Q1 | 109.46 Million CNY | -2.88% |
| 2021 FY | 126.84 Million CNY | 12.54% |
| 2021 Q4 | 126.84 Million CNY | 0.0% |
| 2021 Q3 | 126.84 Million CNY | 15.88% |
| 2021 Q2 | 109.46 Million CNY | 0.0% |
| 2020 FY | 112.71 Million CNY | 66.52% |
| 2020 Q1 | 2.74 Billion CNY | 3962.17% |
| 2020 Q3 | 112.71 Million CNY | 0.52% |
| 2020 Q2 | 112.12 Million CNY | -95.92% |
| 2020 Q4 | 112.71 Million CNY | 0.0% |
| 2019 Q3 | 1.48 Billion CNY | 0.0% |
| 2019 FY | 67.68 Million CNY | 335.62% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q4 | 67.68 Million CNY | -95.45% |
| 2018 FY | 15.53 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| SQZ Biotechnologies Company | 20.9 Million USD | -845.956% |
| Evofem Biosciences, Inc. | 8000.00 USD | -2472275.0% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -11167.01% |
| Mesoblast Limited | 100.29 Million USD | -97.208% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -337183.858% |
| Genus plc | 228.2 Million USD | 13.326% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Marizyme, Inc. | 667.12 Thousand USD | -29547.939% |
| ContraFect Corporation | 2.21 Million USD | -8849.774% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -13998.311% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -3544.904% |
| MultiCell Technologies, Inc. | 36.43 USD | -542931549.739% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 55.61 Million USD | -255.661% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -8785.445% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -16001.944% |
| Biomind Labs Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -19.075% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -10318.401% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -115411.301% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -3588252.685% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| IMV Inc. | 27.39 Million USD | -621.899% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -61325.466% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 11.23 Billion USD | 98.24% |
| Halberd Corporation | 150 Thousand USD | -131760.0% |
| Enzolytics Inc. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 300 Thousand USD | -65830.0% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -120353.092% |
| argenx SE | 15.35 Million USD | -1188.199% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | -873.759% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 4456.00 USD | -4438634.291% |
| Genscript Biotech Corporation | 287.12 Million USD | 31.115% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -156500.846% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -86161.563% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -35564.184% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -781709.558% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -2293.393% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -74359.314% |
| ONE Bio Corp. | 592.19 Thousand USD | -33299.302% |
| Reve Technologies, Inc. | 1064.00 USD | -18589185.714% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -132100.195% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -132100.195% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 229.69 Thousand USD | -86011.341% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | 141 Thousand USD | -140176.596% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -247137.5% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -2429.297% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -53494.509% |
| International Stem Cell Corporation | 445 Thousand USD | -44347.191% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -2326.871% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -43180.088% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -16936.176% |
| PureTech Health plc | 18.25 Million USD | -983.781% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -131760.0% |
| IXICO plc | 275 Thousand USD | -71823.636% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -1570.665% |
| Gelesis Holdings, Inc. | 26.3 Million USD | -651.796% |
| CSL Limited | 11.23 Billion USD | 98.24% |
| Cellectis S.A. | 36.21 Million USD | -446.213% |